<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38543708</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">342</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16030342</ELocationID><Abstract><AbstractText>Throughout the SARS-CoV-2 pandemic, several variants of concern (VOCs) have been identified, many of which share recurrent mutations in the spike glycoprotein's receptor-binding domain (RBD). This region coincides with known epitopes and can therefore have an impact on immune escape. Protracted infections in immunosuppressed patients have been hypothesized to lead to an enrichment of such mutations and therefore drive evolution towards VOCs. Here, we present the case of an immunosuppressed patient that developed distinct populations with immune escape mutations throughout the course of their infection. Notably, by investigating the co-occurrence of substitutions on individual sequencing reads in the RBD, we found quasispecies harboring mutations that confer resistance to known monoclonal antibodies (mAbs) such as S:E484K and S:E484A. These mutations were acquired without the patient being treated with mAbs nor convalescent sera and without them developing a detectable immune response to the virus. We also provide additional evidence for a viral reservoir based on intra-host phylogenetics, which led to a viral substrain that evolved elsewhere in the patient's body, colonizing their upper respiratory tract (URT). The presence of SARS-CoV-2 viral reservoirs can shed light on protracted infections interspersed with periods where the virus is undetectable, and potential explanations for long-COVID cases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fournelle</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Research Centre Montreal Heart Institute, Montr&#xe9;al, QC H1T 1C8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Biochimie et M&#xe9;decine Mol&#xe9;culaire, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3C 3J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mostefai</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Research Centre Montreal Heart Institute, Montr&#xe9;al, QC H1T 1C8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Biochimie et M&#xe9;decine Mol&#xe9;culaire, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3C 3J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunet-Ratnasingham</LastName><ForeName>Elsa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Microbiologie, Infectiologie et Immunologie, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3C 3J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poujol</LastName><ForeName>Rapha&#xeb;l</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Research Centre Montreal Heart Institute, Montr&#xe9;al, QC H1T 1C8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grenier</LastName><ForeName>Jean-Christophe</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Research Centre Montreal Heart Institute, Montr&#xe9;al, QC H1T 1C8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xe1;lvez</LastName><ForeName>Jos&#xe9; H&#xe9;ctor</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Canadian Centre for Computational Genomics, Montr&#xe9;al, QC H3A 0G1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagliuzza</LastName><ForeName>Am&#xe9;lie</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8124-2607</Identifier><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levade</LastName><ForeName>In&#xe8;s</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-3488-7255</Identifier><AffiliationInfo><Affiliation>Laboratoire de Sant&#xe9; Publique du Qu&#xe9;bec, Institut National de Sant&#xe9; Publique du Qu&#xe9;bec, Sainte-Anne-de-Bellevue, QC H9X 3R5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratoire de Sant&#xe9; Publique du Qu&#xe9;bec, Institut National de Sant&#xe9; Publique du Qu&#xe9;bec, Sainte-Anne-de-Bellevue, QC H9X 3R5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benlarbi</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9966-3784</Identifier><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Microbiologie, Infectiologie et Immunologie, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3C 3J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaudoin-Bussi&#xe8;res</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Microbiologie, Infectiologie et Immunologie, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3C 3J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gendron-Lepage</LastName><ForeName>Gabrielle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourassa</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1805-8860</Identifier><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tauzin</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Microbiologie, Infectiologie et Immunologie, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3C 3J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grandjean Lapierre</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Microbiologie, Infectiologie et Immunologie, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3C 3J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chomont</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9747-5018</Identifier><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Microbiologie, Infectiologie et Immunologie, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3C 3J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finzi</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Microbiologie, Infectiologie et Immunologie, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3C 3J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufmann</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0003-4467-136X</Identifier><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CRCHUM), Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Microbiologie, Infectiologie et Immunologie, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3C 3J7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CHUM), Montr&#xe9;al, QC H2X 0C1, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, University Hospital and University of Lausanne, CH-1015 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craig</LastName><ForeName>Morgan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4852-4770</Identifier><AffiliationInfo><Affiliation>Research Centre, Centre Hospitalier UniversitaireSainte-Justine, Montr&#xe9;al, QC H3T 1C5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Math&#xe9;matiques et de Statistique, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3T 1J4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussin</LastName><ForeName>Julie G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0003-4295-3339</Identifier><AffiliationInfo><Affiliation>Research Centre Montreal Heart Institute, Montr&#xe9;al, QC H1T 1C8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de M&#xe9;decine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3C 3J7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mila-Quebec AI Institute, Montr&#xe9;al, QC H2S 3H1, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>174924</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093522" MajorTopicYN="N">COVID-19 Serotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">immune escape mutations</Keyword><Keyword MajorTopicYN="N">phylogenetics</Keyword><Keyword MajorTopicYN="N">viral genomics</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38543708</ArticleId><ArticleId IdType="pmc">PMC10974702</ArticleId><ArticleId IdType="doi">10.3390/v16030342</ArticleId><ArticleId IdType="pii">v16030342</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu Z., VanBlargan L.A., Bloyet L.M., Rothlauf P.W., Chen R.E., Stumpf S., Zhao H., Errico J.M., Theel E.S., Liebeskind M.J., et al. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe. 2021;29:477&#x2013;488.e4. doi: 10.1016/j.chom.2021.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.01.014</ArticleId><ArticleId IdType="pmc">PMC7839837</ArticleId><ArticleId IdType="pubmed">33535027</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton M.I., MacGowan S.A., Kutuzov M.A., Dushek O., Barton G.J., van der Merwe P.A. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. eLife. 2021;10:e70658. doi: 10.7554/eLife.70658.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.70658</ArticleId><ArticleId IdType="pmc">PMC8480977</ArticleId><ArticleId IdType="pubmed">34435953</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah M., Ahmad B., Choi S., Woo H.G. Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization. Comput. Struct. Biotechnol. J. 2020;18:3402&#x2013;3414. doi: 10.1016/j.csbj.2020.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7657873</ArticleId><ArticleId IdType="pubmed">33200028</ArticleId></ArticleIdList></Reference><Reference><Citation>Corey L., Beyrer C., Cohen M.S., Michael N.L., Bedford T., Rolland M. SARS-CoV-2 Variants in Patients with Immunosuppression. N. Engl. J. Med. 2021;385:562&#x2013;566. doi: 10.1056/NEJMsb2104756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb2104756</ArticleId><ArticleId IdType="pmc">PMC8494465</ArticleId><ArticleId IdType="pubmed">34347959</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer E.M., Babiker A., Adelman M.W., Allman B., Key A., Kleinhenz J.M., Langsjoen R.M., Nguyen P.V., Onyechi I., Sherman J.D., et al. SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients. N. Engl. J. Med. 2022;386:2436&#x2013;2438. doi: 10.1056/NEJMc2202861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2202861</ArticleId><ArticleId IdType="pmc">PMC9202319</ArticleId><ArticleId IdType="pubmed">35675197</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen B., Luebke N., Feldt T., Keitel V., Brandenburger T., Kindgen-Milles D., Lutterbeck M., Freise N.F., Schoeler D., Haas R., et al. Emergence of the E484K mutation in SARS-CoV-2-infected immunocompromised patients treated with bamlanivimab in Germany. Lancet Reg. Health Eur. 2021;8:100164. doi: 10.1016/j.lanepe.2021.100164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100164</ArticleId><ArticleId IdType="pmc">PMC8278033</ArticleId><ArticleId IdType="pubmed">34278371</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka C.K.V., Franco M.M., Gr&#xe4;f T., de Lorenzo Barcia C.A., de &#xc1;vila Mendon&#xe7;a R.N., de Sousa K.A.F., Neiva L.M.C., Fosenca V., Mendes A.V.A., de Aguiar R.S., et al.  Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.  [(accessed on 27 September 2023)];Emerg. Infect. Dis. J. 2021 27:5. doi: 10.3201/eid2705.210191. Available online:  https://wwwnc.cdc.gov/eid/article/27/5/21-0191_article.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2705.210191</ArticleId><ArticleId IdType="pmc">PMC8084516</ArticleId><ArticleId IdType="pubmed">33605869</ArticleId></ArticleIdList></Reference><Reference><Citation>Siliciano J.D., Siliciano R.F. In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure. Annu. Rev. Pathol. Mech. Dis. 2022;17:271&#x2013;294. doi: 10.1146/annurev-pathol-050520-112001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-050520-112001</ArticleId><ArticleId IdType="pubmed">34736342</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B., Aleman S., Bach K., Boribong B.P., Buggert M., Cherry S., Chertow D.S., Davies H.E., Dupont C.L., et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Nat. Immunol. 2023;24:1616&#x2013;1627. doi: 10.1038/s41590-023-01601-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01601-2</ArticleId><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Yun K.W., Jeong H., Kim B., Kim M.J., Park J.H., Shin H.S., Oh H.S., Sung H., Song M.G., et al. SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients. Virulence. 2022;13:1242&#x2013;1251. doi: 10.1080/21505594.2022.2101198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2022.2101198</ArticleId><ArticleId IdType="pmc">PMC9336477</ArticleId><ArticleId IdType="pubmed">35891618</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaguza C., Hahn A.M., Petrone M.E., Zhou S., Ferguson D., Breban M.I., Pham K., Pe&#xf1;a-Hern&#xe1;ndez M.A., Castaldi C., Hill V., et al.  Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection.  [(accessed on 27 September 2023)];Cell Rep. Med. 2023 4:100943. doi: 10.1016/j.xcrm.2023.100943. Available online:  https://www.cell.com/cell-reports-medicine/abstract/S2666-3791(23)00035-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2023.100943</ArticleId><ArticleId IdType="pmc">PMC9906997</ArticleId><ArticleId IdType="pubmed">36791724</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandolini M., Zannoli S., Gatti G., Arfilli V., Cricca M., Dirani G., Denicol&#xf2; A., Semprini S., Grumiro L., Imola M., et al. Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient. Viruses. 2023;15:291. doi: 10.3390/v15020291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020291</ArticleId><ArticleId IdType="pmc">PMC9962589</ArticleId><ArticleId IdType="pubmed">36851504</ArticleId></ArticleIdList></Reference><Reference><Citation>Villase&#xf1;or-Echavarri R., Gomez-Romero L., Martin-Onraet A., Herrera L.A., Escobar-Arrazola M.A., Ramirez-Vega O.A., Barrientos-Flores C., Mendoza-Vargas A., Hidalgo-Miranda A., Vilar-Compte D., et al. SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin&#x2019;s Lymphoma. Viruses. 2023;15:377. doi: 10.3390/v15020377.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020377</ArticleId><ArticleId IdType="pmc">PMC9962578</ArticleId><ArticleId IdType="pubmed">36851588</ArticleId></ArticleIdList></Reference><Reference><Citation>Burel E., Colson P., Lagier J.-C., Levasseur A., Bedotto M., Lavrard-Meyer P., Fournier P.-E., La Scola B., Raoult D. Sequential Appearance and Isolation of a SARS-CoV-2 Recombinant between Two Major SARS-CoV-2 Variants in a Chronically Infected Immunocompromised Patient. Viruses. 2022;14:1266. doi: 10.3390/v14061266.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14061266</ArticleId><ArticleId IdType="pmc">PMC9227898</ArticleId><ArticleId IdType="pubmed">35746737</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaranta E.G., Fusaro A., Giussani E., D&#x2019;Amico V., Varotto M., Pagliari M., Giordani M.T., Zoppelletto M., Merola F., Antico A., et al. SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient. Int. J. Infect. Dis. 2022;122:444&#x2013;448. doi: 10.1016/j.ijid.2022.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.06.023</ArticleId><ArticleId IdType="pmc">PMC9212919</ArticleId><ArticleId IdType="pubmed">35724829</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudoin-Bussi&#xe8;res G., Laumaea A., Anand S.P., Pr&#xe9;vost J., Gasser R., Goyette G., Medjahed H., Perreault J., Tremblay T., Lewin A., et al. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals. mBio. 2020;11:e02590-20. doi: 10.1128/mBio.02590-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02590-20</ArticleId><ArticleId IdType="pmc">PMC7569150</ArticleId><ArticleId IdType="pubmed">33067385</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Chen Y., Pr&#xe9;vost J., Ullah I., Lu M., Gong S.Y., Tauzin A., Gasser R., V&#xe9;zina D., Anand S.P., et al. Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern. Cell Rep. 2022;38:110210. doi: 10.1016/j.celrep.2021.110210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110210</ArticleId><ArticleId IdType="pmc">PMC8673750</ArticleId><ArticleId IdType="pubmed">34971573</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xe9;vost J., Gasser R., Beaudoin-Bussi&#xe8;res G., Richard J., Duerr R., Laumaea A., Anand S.P., Goyette G., Benlarbi M., Ding S., et al. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike. Cell Rep. Med. 2020;1:100126. doi: 10.1016/j.xcrm.2020.100126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100126</ArticleId><ArticleId IdType="pmc">PMC7524645</ArticleId><ArticleId IdType="pubmed">33015650</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauzin A., Nayrac M., Benlarbi M., Gong S.Y., Gasser R., Beaudoin-Bussi&#xe8;res G., Brassard N., Laumaea A., V&#xe9;zina D., Pr&#xe9;vost J., et al. A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses. Cell Host Microbe. 2021;29:1137&#x2013;1150.e6. doi: 10.1016/j.chom.2021.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.06.001</ArticleId><ArticleId IdType="pmc">PMC8175625</ArticleId><ArticleId IdType="pubmed">34133950</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudoin-Bussi&#xe8;res G., Richard J., Pr&#xe9;vost J., Goyette G., Finzi A. A new flow cytometry assay to measure antibody-dependent cellular cytotoxicity against SARS-CoV-2 Spike-expressing cells. STAR Protoc. 2021;2:100851. doi: 10.1016/j.xpro.2021.100851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2021.100851</ArticleId><ArticleId IdType="pmc">PMC8435374</ArticleId><ArticleId IdType="pubmed">34541555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgey M., Dali R., Eveleigh R., Chen K.C., Letourneau L., Fillon J., Michaud M., Caron M., Sandoval J., Lefebvre F., et al. GenPipes: An open-source framework for distributed and scalable genomic analyses. GigaScience. 2019;8:giz037. doi: 10.1093/gigascience/giz037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gigascience/giz037</ArticleId><ArticleId IdType="pmc">PMC6559338</ArticleId><ArticleId IdType="pubmed">31185495</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Toole &#xc1;., Scher E., Underwood A., Jackson B., Hill V., McCrone J.T., Colquhoun R., Ruis C., Abu-Dahab K., Taylor B., et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 2021;7:veab064. doi: 10.1093/ve/veab064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab064</ArticleId><ArticleId IdType="pmc">PMC8344591</ArticleId><ArticleId IdType="pubmed">34527285</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield J., Megill C., Bell S.M., Huddleston J., Potter B., Callender C., Sagulenko P., Bedford T., Neher R.A. Nextstrain: Real-time tracking of pathogen evolution. Bioinformatics. 2018;34:4121&#x2013;4123. doi: 10.1093/bioinformatics/bty407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty407</ArticleId><ArticleId IdType="pmc">PMC6247931</ArticleId><ArticleId IdType="pubmed">29790939</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodsi A., Meriranta L., Pasanen A., Lepp&#xe4; S. ctDNAtools: An R package to work with sequencing data of circulating tumor DNA.  [(accessed on 27 September 2023)];bioRxiv. 2020 :bioRxiv:2020.01.27.912790. Available online:  https://www.biorxiv.org/content/10.1101/2020.01.27.912790v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.01.27.912790v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauzin A., Nicolas A., Ding S., Benlarbi M., Medjahed H., Chatterjee D., Dionne K., Gong S.Y., Gendron-Lepage G., Bo Y., et al. Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine. Cell Rep. 2023;42:111998. doi: 10.1016/j.celrep.2023.111998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.111998</ArticleId><ArticleId IdType="pmc">PMC9826988</ArticleId><ArticleId IdType="pubmed">36656710</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xe9;vost J., Richard J., Gasser R., Ding S., Fage C., Anand S.P., Adam D., Gupta Vergara N., Tauzin A., Benlarbi M., et al.  Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2.  [(accessed on 27 September 2023)];J. Biol. Chem. 2021 297:101151.  doi: 10.1016/j.jbc.2021.101151. Available online:  https://www.jbc.org/article/S0021-9258(21)00952-2/abstract.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101151</ArticleId><ArticleId IdType="pmc">PMC8406544</ArticleId><ArticleId IdType="pubmed">34478710</ArticleId></ArticleIdList></Reference><Reference><Citation>Harari S., Tahor M., Rutsinsky N., Meijer S., Miller D., Henig O., Halutz O., Levytskyi K., Ben-Ami R., Adler A., et al. Drivers of adaptive evolution during chronic SARS-CoV-2 infections. Nat. Med. 2022;28:1501&#x2013;1508. doi: 10.1038/s41591-022-01882-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01882-4</ArticleId><ArticleId IdType="pmc">PMC9307477</ArticleId><ArticleId IdType="pubmed">35725921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hettle D., Hutchings S., Muir P., Moran E. Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review. Clin. Infect. Pract. 2022;16:100210. doi: 10.1016/j.clinpr.2022.100210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinpr.2022.100210</ArticleId><ArticleId IdType="pmc">PMC9666269</ArticleId><ArticleId IdType="pubmed">36405361</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Choudhary M.C., Regan J., Boucau J., Nathan A., Speidel T., Liew M.Y., Edelstein G.E., Kawano Y., Uddin R., et al. SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency. Sci. Transl. Med. 2024;16:eadk1599. doi: 10.1126/scitranslmed.adk1599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.adk1599</ArticleId><ArticleId IdType="pmc">PMC10982957</ArticleId><ArticleId IdType="pubmed">38266109</ArticleId></ArticleIdList></Reference><Reference><Citation>Simsek C., Erul E., Balaban H.Y. Role of gastrointestinal system on transmission and pathogenesis of SARS-CoV-2. World J. Clin. Cases. 2021;9:5427&#x2013;5434. doi: 10.12998/wjcc.v9.i20.5427.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v9.i20.5427</ArticleId><ArticleId IdType="pmc">PMC8281423</ArticleId><ArticleId IdType="pubmed">34307596</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-Acute Coronavirus Disease 2019 Sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D., Lim J.C.T., Fern&#xe1;ndez S.B., Lee J.N., Joseph C.R., Neo Z.W., Guerrero S., Lau M.C., Sheng J.Y.P. Persistence of Residual SARS-CoV-2 Viral Antigen and RNA in Tissues of Patients with Long COVID-19. 2022.  [(accessed on 27 September 2023)].  Available online:  https://www.scienceopen.com/document?vid=3a2fc703-60c8-4e5d-aa00-18fd6a9fc846.</Citation></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P., Casari G., Townsend L., O&#x2019;Farrelly C., Tancevski I., L&#xf6;ffler-Ragg J., Mogensen T.H., Casanova J.L., The COVID Human Genetic Effort Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat. Med. 2022;28:879&#x2013;882. doi: 10.1038/s41591-022-01766-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Col&#xf3;n G.J., Ratnasiri K., Chen H., Jiang S., Zanley E., Rustagi A., Verma R., Chen H., Andrews J.R., Mertz K.D., et al. SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages. Sci. Transl. Med. 2022;14:eabm9151. doi: 10.1126/scitranslmed.abm9151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abm9151</ArticleId><ArticleId IdType="pmc">PMC9529056</ArticleId><ArticleId IdType="pubmed">36137009</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Iketani S., Guo Y., Chan J.F., Wang M., Liu L., Luo Y., Chu H., Huang Y., Nair M.S., et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature. 2022;602:676&#x2013;681. doi: 10.1038/s41586-021-04388-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04388-0</ArticleId><ArticleId IdType="pubmed">35016198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill V., Du Plessis L., Peacock T.P., Aggarwal D., Colquhoun R., Carabelli A.M., Ellaby N., Gallagher E., Groves N., Jackson B., et al. The origins molecular evolution of SARS-CoV-2 lineage B117 in the UK. Virus Evol. 2022;8:veac080. doi: 10.1093/ve/veac080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac080</ArticleId><ArticleId IdType="pmc">PMC9752794</ArticleId><ArticleId IdType="pubmed">36533153</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>